<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154820">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02048891</url>
  </required_header>
  <id_info>
    <org_study_id>RMB-0427-13</org_study_id>
    <nct_id>NCT02048891</nct_id>
  </id_info>
  <brief_title>Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ovulation trigger is needed in IVF to get mature eggs. Routinely, hCG is used for that
      purpose given its similarity to the natural hormone that does this job in a natural cycle
      (luteinizing hormone, LH). In a natural cycle another hormone takes part in the process
      (FSH). To induce a natural-like ovulation surge that includes LH and FSH , GnRH agonist can
      be given.

      The purpose of this study is to find out which approach may work better in IVF patients who
      experienced 4 IVF failures.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Fetal heart activity 1 month after oocyte retrieval</measure>
    <time_frame>1 month after oocyte retrieval</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patients comfort during the luteal phase</measure>
    <time_frame>During 2 weeks from day of oocyte retrieval</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>hCG trigger</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ovulation trigger with Ovitrelle 250 microgram, luteal support with vaginal progesterone: gel Crinone 8% daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GnRH agonist trigger</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ovulation trigger with Decapeptyl 0.2 mg, luteal support with 2 injections of 1,500 U hCG.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GnRH agonist trigger</intervention_name>
    <arm_group_label>GnRH agonist trigger</arm_group_label>
    <other_name>Oovulation trigger with Decapeptyl 0.2 mg, luteal support with 2 injections of 1,500 U hCG.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>hCG trigger</intervention_name>
    <arm_group_label>hCG trigger</arm_group_label>
    <other_name>Ovulation trigger with Ovitrelle 250 microgram.</other_name>
    <other_name>Luteal support with daily progesterone gel = Crinone 8%</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IVF patients with at least 4 consecutive failures.

          -  On trigger day, no more than 10 follicles of 12 mm and up

        Exclusion Criteria:

          -  History of moderate or severe OHSS.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shahar Kol, Assistant professor</last_name>
    <phone>972-4-8543232</phone>
    <email>skol@rambam.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>IVF Unit, Rambam medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31096</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shahar Kol, Assistant professor</last_name>
      <phone>972-4-8543232</phone>
      <email>skol@rambam.health.gov.il</email>
    </contact>
    <investigator>
      <last_name>Shahar Kol, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 28, 2014</lastchanged_date>
  <firstreceived_date>January 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Shahar Kol MD</investigator_full_name>
    <investigator_title>Director, IVF Unit</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Progesterone</mesh_term>
    <mesh_term>Deslorelin</mesh_term>
    <mesh_term>Triptorelin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
